[Form 4] Leidos Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Leidos Holdings, Inc. director Tina W. Jonas reported equity awards on Common Stock. She received 1,067 shares of Common Stock as a grant with no cash paid per share, increasing her direct holdings to 2,446 shares after the transaction.

She also received a stock option for 1,281 shares of Common Stock with an exercise price of $131.26 per share. The option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholder meeting, and expires in 2033. Following this grant, she holds 1,281 stock options directly.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Jonas Tina W

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,281	$0.00	--
Grant/Award	Common Stock	1,067	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 1,281 shares (Direct, null); Common Stock — 2,446 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Common Stock grant: 1,067 shares Shares held after grant: 2,446 shares Stock options granted: 1,281 options +3 more

6 metrics

Common Stock grant 1,067 shares Awarded on May 8, 2026 as a grant

Shares held after grant 2,446 shares Direct Common Stock holdings following transaction

Stock options granted 1,281 options Stock Option (Right to Buy) granted May 8, 2026

Option exercise price $131.26 per share Conversion/exercise price for 1,281 stock options

Option vesting trigger Earlier of 1-year or next annual meeting Vesting condition from Form 4 footnote

Option expiration date May 7, 2033 Final date to exercise granted stock options

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, vesting, +1 more

5 terms

Stock Option (Right to Buy) financial

"She also received a stock option for 1,281 shares of Common Stock with an exercise price of $131.26 per share."

Grant, award, or other acquisition financial

"Both awards are coded as a grant, award, or other acquisition in the filing."

exercise price financial

"She also received a stock option for 1,281 shares of Common Stock with an exercise price of $131.26 per share."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholder meeting."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

expiration date financial

"The newly granted stock options to Tina W. Jonas expire in 2033."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jonas Tina W

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VIRGINIA 20190

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		A		1,067	A	$0	2,446	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$131.26	05/08/2026		A		1,281		05/08/2027(1)	05/07/2033	Common Stock	1,281	$0	1,281	D

Explanation of Responses:

1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Remarks:

	/s/ Ramune M. Kligys by PoA of Tina W. Jonas	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Leidos (LDOS) director Tina W. Jonas report?

Tina W. Jonas reported receiving equity awards from Leidos. She acquired 1,067 shares of Common Stock as a grant and 1,281 stock options, both recorded as compensation-related awards rather than open-market purchases or sales.

How many Leidos (LDOS) shares does Tina W. Jonas own after this Form 4?

After the reported grant, Tina W. Jonas directly holds 2,446 shares of Leidos Common Stock. This figure reflects her position immediately following the 1,067-share award disclosed in the Form 4 insider transaction filing.

What are the terms of Tina W. Jonas’s new Leidos (LDOS) stock options?

She received stock options covering 1,281 shares of Leidos Common Stock with an exercise price of $131.26 per share. The options vest fully on the earlier of one year from the grant date or the conclusion of the next annual stockholder meeting.

When do the newly granted Leidos (LDOS) stock options expire?

The newly granted stock options to Tina W. Jonas expire in 2033. Specifically, the expiration date is disclosed as May 7, 2033, setting the final date by which the options may be exercised, subject to vesting conditions.

Is Tina W. Jonas’s Leidos (LDOS) Form 4 a purchase or a compensation grant?

The Form 4 reflects compensation grants, not open-market purchases. Both the 1,067 Common Stock shares and 1,281 stock options are coded as “A” for grant, award, or other acquisition, with zero purchase price per share reported in the filing.

What vesting condition applies to the new Leidos (LDOS) stock options?

The stock options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the date the next annual Leidos stockholder meeting concludes, according to the footnote describing the vesting terms in the filing.